{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:25:16Z","timestamp":1793395516981,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/mbc.0000000000000336","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T11:59:48Z","timestamp":1437479988000},"page":"655-660","source":"Crossref","is-referenced-by-count":16,"title":["Safety and efficacy of the use of institutional unfractionated heparin protocols for therapeutic anticoagulation in obese patients"],"prefix":"10.1097","volume":"26","author":[{"given":"Sooyoung","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth F.","family":"Harthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity.","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012.","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association.","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ijo.2012.159","article-title":"Morbid obesity rates continue to rise rapidly in the United States.","volume":"37","author":"Sturm","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism.","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1538-7836.2011.04334.x","article-title":"How to prevent, treat, and overcome current clinical challenges of VTE.","volume":"9","author":"Van Es","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ccc.2010.06.011","article-title":"Venous thromboembolic disease and hematologic considerations in obesity.","volume":"26","author":"Craft","year":"2010","journal-title":"Crit Care Clin"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism.","volume":"168","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1345\/aph.1P088","article-title":"Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.","volume":"44","author":"Riney","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"Suppl 6","key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/ajhp\/58.22.2143","article-title":"Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients.","volume":"58","author":"Spruill","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4065\/mcp.2009.0220","article-title":"Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.","volume":"84","author":"Bauer","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0749-0704(05)70159-7","article-title":"Management of the obese critically ill patient.","volume":"17","author":"Varon","year":"2001","journal-title":"Crit Care Clin"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.soard.2008.03.005","article-title":"Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity.","volume":"4","author":"Barletta","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ajhp\/55.2.159","article-title":"Optimal weight base for a weight-based heparin dosing protocol.","volume":"55","author":"Yee","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.1981.53","article-title":"Heparin kinetics: variables related to disposition and dosage.","volume":"29","author":"Cipolle","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004020050392","article-title":"Weight-based heparin dosing is more effective in the treatment of postoperative deep vein thrombosis.","volume":"119","author":"Linke","year":"1999","journal-title":"Arch Orthop Trauma Surg"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ccc.2010.07.003","article-title":"Pharmacotherapy in the critically ill obese patient.","volume":"26","author":"Medico","year":"2010","journal-title":"Crit Care Clin"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a standard care nomogram. A randomized controlled trial.","volume":"119","author":"Raschke","year":"1993","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"e24s","DOI":"10.1378\/chest.11-2291","article-title":"American College of Chest Physicians. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/2229-5151.119200","article-title":"Comparison of heparin dosing based on actual body weight in nonobese, obese and morbidly obese critically ill patients.","volume":"3","author":"Gerlach","year":"2013","journal-title":"Int J Crit Illn Inj Sci"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1310\/hpj4311-895","article-title":"Safety and efficacy of a high-intensity, weight-based, intravenous heparin protocol revision in patients who are obese.","volume":"43","author":"Dee","year":"2008","journal-title":"Hosp Pharm"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"909135","DOI":"10.1155\/2013\/909135","article-title":"A real-world, multicenter assessment of drugs requiring weight-based calculations in overweight, adult critically ill patients.","volume":"2013","author":"Kane-Gill","year":"2013","journal-title":"Sci World J"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2141.2011.08826.x","article-title":"Anticoagulating obese patients in the modern era.","volume":"155","author":"Patel","year":"2011","journal-title":"Br J Haematol"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans.","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0149-2918(98)80133-1","article-title":"Weight-based heparin dosing: clinical response and resource utilization.","volume":"20","author":"Lackie","year":"1998","journal-title":"Clin Ther"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/j.1875-9114.1996.tb03036.x","article-title":"Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.","volume":"16","author":"Shalansky","year":"1996","journal-title":"Pharmacotherapy"},{"key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1160\/TH06-05-0290","article-title":"Monitoring unfractionated heparin with the aPTT: time for a fresh look.","volume":"96","author":"Eikelboom","year":"2006","journal-title":"Thromb Haemost"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201509000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:03Z","timestamp":1786039083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201509000-00009"}},"subtitle":["a retrospective chart review"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000336","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}